Pharmafile Logo
Pharmafocus logo
Advanced Search

Vical

Showing 3 posts of 3 posts found.

shutterstock_339308225

Vical terminates genital herpes vaccine after trial failure

June 12, 2018
Manufacturing and Production, Research and Development Vaccine, Vical, herpes, pharma

San Diego-based biopharma firm Vical has announced the disappointing, if unsurprising, news that it has taken the decision to terminate …

News
Vical image

Vical melanoma drug dropped

August 13, 2013
Research and Development, Sales and Marketing Vical, allovectin, melanoma

Vical has abandoned trials of a late-stage drug for the deadliest form of skin cancer after the treatment failed to …

News

Pharma manufacturing news in brief

October 26, 2010
Manufacturing and Production AMRI, BASF, BMS, Bend Research, Bristol-Myers Squibb, Parmetics, Stirling Pharma, Vical, pharma manufacturing

This week’s round-up of pharmaceutical manufacturing news features updates from Pharmetics, AMRI, Bend Research/BMS, Stirling Pharma, Vical and BASF. A …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026